ATE437368T1 - Verfahren zum prüfen von mit wt1-verbundenen krankheiten - Google Patents
Verfahren zum prüfen von mit wt1-verbundenen krankheitenInfo
- Publication number
- ATE437368T1 ATE437368T1 AT01932243T AT01932243T ATE437368T1 AT E437368 T1 ATE437368 T1 AT E437368T1 AT 01932243 T AT01932243 T AT 01932243T AT 01932243 T AT01932243 T AT 01932243T AT E437368 T1 ATE437368 T1 AT E437368T1
- Authority
- AT
- Austria
- Prior art keywords
- testing
- disease
- related diseases
- course
- value
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57426—Specifically defined cancers leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/18—Togaviridae; Flaviviridae
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000152923 | 2000-05-24 | ||
JP2001014927A JP3846199B2 (ja) | 2000-05-24 | 2001-01-23 | Wt1関連疾患の検査方法 |
PCT/JP2001/004353 WO2001090750A1 (fr) | 2000-05-24 | 2001-05-24 | Procédé d'examen d'une maladie liée au gene wt1 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE437368T1 true ATE437368T1 (de) | 2009-08-15 |
Family
ID=26592471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01932243T ATE437368T1 (de) | 2000-05-24 | 2001-05-24 | Verfahren zum prüfen von mit wt1-verbundenen krankheiten |
Country Status (11)
Country | Link |
---|---|
US (2) | US7824865B2 (de) |
EP (2) | EP2045604B1 (de) |
JP (1) | JP3846199B2 (de) |
KR (3) | KR20030014238A (de) |
AT (1) | ATE437368T1 (de) |
AU (2) | AU5882701A (de) |
CA (2) | CA2704596C (de) |
DE (1) | DE60139314D1 (de) |
ES (2) | ES2389328T3 (de) |
PT (1) | PT2045604E (de) |
WO (1) | WO2001090750A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4592641B2 (ja) * | 2000-05-24 | 2010-12-01 | 治夫 杉山 | Wt1関連疾患の検査方法 |
JP2007322211A (ja) * | 2006-05-31 | 2007-12-13 | Green Peptide Co Ltd | がん患者の予後予測方法 |
EP2255194A1 (de) * | 2008-02-28 | 2010-12-01 | Thurnher, Martin | Verfahren zur prognose des zustandes von tumorpatienten |
JP6122779B2 (ja) * | 2011-09-14 | 2017-04-26 | 株式会社癌免疫研究所 | 抗wt1抗体の測定方法 |
KR20160007579A (ko) * | 2013-05-13 | 2016-01-20 | 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 | 면역요법의 임상 효과의 예측법 |
JP6537805B2 (ja) * | 2014-10-29 | 2019-07-03 | 日本航空電子工業株式会社 | レバー式コネクタ |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5622835A (en) * | 1994-04-28 | 1997-04-22 | The Wistar Institute Of Anatomy & Biology | WT1 monoclonal antibodies |
CA2224970C (en) | 1996-04-16 | 2002-04-02 | Kishimoto, Tadamitsu | Method of detecting solid cancer cells and tissue atypia and method of testing tissues for use in bone marrow transplantation and peripheral blood stem cell transplantation |
ATE399179T1 (de) * | 1998-09-30 | 2008-07-15 | Corixa Corp | Zusammensetzungen und verfahren für wt1- spezifische immunotherapie |
US20030215458A1 (en) * | 1998-09-30 | 2003-11-20 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
US7063854B1 (en) * | 1998-09-30 | 2006-06-20 | Corixa Corporation | Composition and methods for WTI specific immunotherapy |
US7144581B2 (en) * | 2000-10-09 | 2006-12-05 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
US7329410B1 (en) * | 1998-09-30 | 2008-02-12 | Corixa Corporation | Compositions and method for WT1 specific immunotherapy |
US7115272B1 (en) * | 1998-09-30 | 2006-10-03 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
US20030082194A1 (en) * | 2000-02-22 | 2003-05-01 | Alexander Gaiger | Compositions and methods for diagnosis and therapy of malignant mesothelioma |
-
2001
- 2001-01-23 JP JP2001014927A patent/JP3846199B2/ja not_active Expired - Lifetime
- 2001-05-24 EP EP09150609A patent/EP2045604B1/de not_active Expired - Lifetime
- 2001-05-24 EP EP01932243A patent/EP1288661B1/de not_active Expired - Lifetime
- 2001-05-24 KR KR1020027015826A patent/KR20030014238A/ko not_active Application Discontinuation
- 2001-05-24 CA CA2704596A patent/CA2704596C/en not_active Expired - Lifetime
- 2001-05-24 CA CA2409208A patent/CA2409208C/en not_active Expired - Lifetime
- 2001-05-24 PT PT09150609T patent/PT2045604E/pt unknown
- 2001-05-24 KR KR1020107017676A patent/KR101141319B1/ko active IP Right Grant
- 2001-05-24 ES ES09150609T patent/ES2389328T3/es not_active Expired - Lifetime
- 2001-05-24 WO PCT/JP2001/004353 patent/WO2001090750A1/ja active IP Right Grant
- 2001-05-24 ES ES01932243T patent/ES2328107T3/es not_active Expired - Lifetime
- 2001-05-24 AT AT01932243T patent/ATE437368T1/de not_active IP Right Cessation
- 2001-05-24 AU AU5882701A patent/AU5882701A/xx active Pending
- 2001-05-24 DE DE60139314T patent/DE60139314D1/de not_active Expired - Lifetime
- 2001-05-24 KR KR1020087013508A patent/KR101056752B1/ko active IP Right Grant
- 2001-05-24 AU AU2001258827A patent/AU2001258827B2/en not_active Ceased
-
2005
- 2005-01-19 US US11/037,128 patent/US7824865B2/en not_active Expired - Fee Related
-
2010
- 2010-10-25 US US12/911,439 patent/US9086415B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2409208C (en) | 2011-02-22 |
CA2409208A1 (en) | 2001-11-29 |
DE60139314D1 (de) | 2009-09-03 |
EP2045604A1 (de) | 2009-04-08 |
AU5882701A (en) | 2001-12-03 |
KR101056752B1 (ko) | 2011-08-12 |
JP2002048793A (ja) | 2002-02-15 |
EP2045604B1 (de) | 2012-08-29 |
US20110124123A1 (en) | 2011-05-26 |
KR20080066862A (ko) | 2008-07-16 |
US20050148037A1 (en) | 2005-07-07 |
EP1288661A1 (de) | 2003-03-05 |
KR101141319B1 (ko) | 2012-05-04 |
ES2328107T3 (es) | 2009-11-10 |
EP1288661A4 (de) | 2006-07-05 |
PT2045604E (pt) | 2012-11-05 |
WO2001090750A1 (fr) | 2001-11-29 |
EP1288661B1 (de) | 2009-07-22 |
US9086415B2 (en) | 2015-07-21 |
JP3846199B2 (ja) | 2006-11-15 |
CA2704596C (en) | 2016-12-06 |
AU2001258827B2 (en) | 2005-06-09 |
KR20030014238A (ko) | 2003-02-15 |
US7824865B2 (en) | 2010-11-02 |
ES2389328T3 (es) | 2012-10-25 |
CA2704596A1 (en) | 2001-11-29 |
KR20100095478A (ko) | 2010-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE489633T1 (de) | Verfahren zum frühzeitigen nachweis herzerkrankungen | |
KR100711046B1 (ko) | 대장암에 대한 마커로서의 니코틴아미드n―메틸트랜스퍼라아제의 용도 | |
CY1112563T1 (el) | Διαταξη και μεθοδος για τον ταυτοχρονο προσδιορισμο των αντιγονων των ομαδων του αιματος | |
HK1079568A1 (en) | A diagnostic reagent for cancer and a diagnostic kit for cancer, comprising an anti-gpc3 antibody | |
WO2003043487A3 (en) | Method of using a non-antibody protein to detect and measure an analyte | |
DE60025347D1 (de) | Methoden zur vohersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests | |
ATE476525T1 (de) | Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern | |
DE602004019812D1 (de) | Marker für neuromyelitis optica | |
CA2701341A1 (en) | Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex | |
DE60129151D1 (de) | Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6) | |
HUP0303888A2 (hu) | FKBP-nukleinsavak és -polipeptidek prosztatarák diagnosztizálására és gyógykezelésére alkalmas expressziós analízise | |
WO2005040759A3 (en) | Apparatus and methods for detecting target analyte | |
ATE437368T1 (de) | Verfahren zum prüfen von mit wt1-verbundenen krankheiten | |
DE602005013430D1 (de) | Verwendung von asc als marker für kolorektalkarzinome | |
ATE478337T1 (de) | Methoden zum nachweis analyten in proben | |
ATE466937T1 (de) | Verfahren zum nachweis von leberkrebs, diagnostikum für leberkrebs sowie heilmittel gegen krebs | |
DE602004017317D1 (de) | Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome | |
CY1109461T1 (el) | Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου | |
HUP0303890A2 (hu) | Differenciációs nukleinsavak és polipeptidek inhibitorának prosztatarák diagnosztizálására és gyógykezelésére alkalmas expressziós analízise | |
ATE432364T1 (de) | Sonden zum nachweis von tumorzellen | |
ATE426171T1 (de) | VERFAHREN UND REAGENZ ZUR PRUFUNG VON MEHRORGANSTÍRUNG IN ßSYSTEMIC INFLAMMATORY RESPONSE SYNDROMEß (SIRS) DURCH MESSUNG VON CYTOCHROM C | |
CY1106705T1 (el) | Δοκιμασια για μετρηση ολο-τρανσκοβαλαμινης και φολικου | |
DE69928213D1 (de) | Verfahren zum bestimmen humaner thymidylatsynthase und versuchskit | |
DE59910326D1 (de) | Verwendung derivatisierter Reagenzien in Chemilumineszenz- und Elektrochemilumineszenz-Nachweisverfahren | |
ATE462976T1 (de) | Quantifizierung durch kombinatorische verdünnung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |